There were 1,838 press releases posted in the last 24 hours and 399,975 in the last 365 days.

HPV Causes Genital Warts and Cancer in Men; CBCD Reviews the Medical Evidence

Most genital warts develop following infection with HPV 6, 11, or 16. (1)

We recommend that men infected with the HPV virus take Gene-Eden-VIR or Novirin.
— Greg Bennett
ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, June 22, 2015 /EINPresswire.com/ --

“Infected with the human papillomavirus (HPV)? The CBCD recommends taking Gene-Eden-VIR or Novirin.” - Greg Bennett, CBCD

A study that included 3,033 men found that up to 22% of those with an HPV infection went on to develop genital warts. (1) But, genital warts are just one result of an HPV infection in men. HPV can also cause various cancers, and has been linked to damaged sperm. For example, another study found that HPV can also cause “anal, penile, and oropharyngeal cancers.” (2) And yet another study showed that “A high incidence of HPV infection has been reported in sperm from sexually active men… and from infertile patients (3).” In addition, they wrote that sperm in HPV and Ct (Chlamydia trachomatis) infected men did not move or “swim” like healthy sperm. The Center for the Biology of Chronic Disease (CBCD) recommends that men infected with HPV take Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was shown to reduce symptoms associated with HPV infection in two separate post-marketing studies that followed FDA guidelines.

Click to learn more about HPV symptoms.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the HPV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HPV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (4) The study authors also wrote that “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (4)

Both products can be ordered online on the Gene-Eden-VIR and Novirin websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

Dr. Anna R. Giuliano and colleagues wrote that “HPV16 (6.5%), HPV51 (5.3%), and HPV59 (5.3%) were the most commonly detected oncogenic (cancer causing) infections, and HPV84 (7.7%), HPV62 (7.3%), and HPV6 (6.6%) were the most commonly detected nononcogenic infections … among the nononcogenic (non-cancer causing, or low-risk) infections … HPV84 was the most commonly detected HPV type in Mexico and the United States.” (2) Dr. Giuliano is from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.

Are there treatments available against the HPV?

“There are no drugs approved against the HPV. Current treatments include procedures, such as cryotherapy, conization, and the Loop Electrosurgical Excision Procedure (LEEP). These procedures use liquid nitrogen, a surgical knife (scalpel), a carbon dioxide (CO2) laser, or electrical current to remove the abnormal growths caused by the HPV. These growths include cells that harbor the active virus. The procedures do not target cells with the latent virus. Since they do not remove the latent virus, these procedures only produce a temporary remission.” (4) In contrast, Novirin and Gene-Eden-VIR were designed to target the latent HPV.

“We recommend that men infected with the HPV virus take Gene-Eden-VIR or Novirin.” - Greg Bennett, CBCD

Individuals interested in viewing published studies on the formula of Novirin and Gene-Eden-VIR can go here:

http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.U-s9ouOSz90 

and

http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.U-s9w-OSz90

All orders of Gene-Eden-VIR and Novirin are completely confidential, and no information is shared or sold to any third party. Privacy is assured.


References:

(1) Sudenga SL, Ingles DJ, Pierce Campbell CM, Lin HY, Fulp WJ, Messina JL, Stoler MH2, Abrahamsen M, Villa LL, Lazcano-Ponce E, Giuliano AR. "Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study." Eur Urol. 2015 Jun 4. pii: S0302-2838(15)00434-0.

(2) Anna R. Giuliano, Eduardo Lazcano-Ponce, Luisa L. Villa, Roberto Flores, Jorge Salmeron, Ji-Hyun Lee, Mary R. Papenfuss, Martha Abrahamsen, Emily Jolles, Carrie M. Nielson, Maria Luisa Baggio, Roberto Silva, and Manuel Quiterio "The Human Papillomavirus Infection in Men Study: Human Papillomavirus Prevalence and Type Distribution among Men Residing in Brazil, Mexico, and the United States" Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8): 2036–2043.

(3) Cai T, Wagenlehner FM, Mondaini N, D'Elia C, Meacci F, Migno S, Malossini G, Mazzoli S, Bartoletti R. "Effect of human papillomavirus and Chlamydia trachomatis co-infection on sperm quality in young heterosexual men with chronic prostatitis-related symptoms." BJU Int. 2014 Feb;113(2):281-7.

(4) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8http://dx.doi.org/10.4236/pp.2013.46A001

Greg Bennett
CBCD
585-250-9999
email us here